Aranciamycin (CAS 72389-06-1)

Aranciamycin is an anthracycline antibiotic isolated from certain strains of the bacterium Streptomyces echinatus. Structurally similar to more prominent anthracyclines like doxorubicin, aranciamycin primarily functions by intercalating into DNA, thereby blocking the transcription and replication processes essential for cell proliferation. Its capacity to bind DNA is facilitated by its planar chromophore, which allows it to insert between base pairs, disrupting the normal topological twists of the DNA helix and inhibiting the action of DNA topoisomerase II, an enzyme critical for DNA replication. This mode of action has made aranciamycin a valuable chemical in the study of DNA interactions and the cellular responses to DNA damage. Research with aranciamycin has contributed to a deeper understanding of the molecular basis of DNA intercalation and its consequences on cellular processes. Furthermore, its use in comparative studies with other anthracyclines helps in discerning the structural and functional nuances that influence the efficacy and specificity of DNA-binding drugs. In scientific research, aranciamycin aids in exploring the regulatory mechanisms of gene expression, providing insights into the cellular architecture and its modulation under the influence of DNA-binding agents.